GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Solgenics Ltd (LSE:SGN) » Definitions » Capital Expenditure

Solgenics (LSE:SGN) Capital Expenditure : £-0.08 Mil (TTM As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is Solgenics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Solgenics's cash flow for capital expenditures for the six months ended in Jun. 2022 was £-0.01 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2022 was £-0.08 Mil.

Solgenics Capital Expenditure Historical Data

The historical data trend for Solgenics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solgenics Capital Expenditure Chart

Solgenics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.03 -0.04 -0.14 -0.13

Solgenics Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.13 -0.05 -0.07 -0.01

Solgenics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solgenics (LSE:SGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Solgenics Ltd (LSE:SGN) » Definitions » Capital Expenditure
Comparable Companies
LSE:EDL LSE:GCM LSE:ORCP SHSE:601088 BOM:512599 SHSE:601225 SHSE:600188 SHSE:601898 NSE:COALINDIA ISX:BYAN SZSE:000983 SHSE:601699 ISX:ADRO ASX:SOL ISX:ADMR ASX:YAL SHSE:601666 SHSE:600157 SHSE:900948 SZSE:000933
Traded in Other Exchanges
N/A
Address
Coastal Building, Wickhams Cay II, P.O. Box 2221, Carrot Bay, Tortola, Road Town, VGB
Website
https://www.solgenics.com
Solgenics Ltd is an African renewable energy development company focused on the development of 300MW solar PV plus BESS renewable energy in the Tete Province in northern Mozambique. Its flagship project comprise Tete Solar Project.